Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 15, 2017 (Vol. 37, No. 16)

Supplement: MilliporeSigma Sees Opportunity in Continuous Processing

From the <i>GEN</i> Sounds of Science Podcast

  • Continuous bioprocessing is generating considerable excitement in the biopharma industry as it promises to increase efficiency, decrease equipment footprint, increase facility flexibility and, ultimately, lower cost of goods. John Sterling, GEN 's editor-in-chief, recently spoke to Merrilee Whitney, director of marketing, next-generation processing at MilliporeSigma, to find out ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.